| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_157f29f291ed3a4b86e2c15b71083ad0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-23015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6486 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2001-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4b01614733bca75e07651f0a20f8b65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2d93c877743108b6a4445d6390f4554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee93f3b10cfbcaf0bfbb96e645df4941 |
| publicationDate |
2004-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-005310-B1 |
| titleOfInvention |
Antihypertensives |
| abstract |
A method of selection of substances capable of controlling the activation of prorenin is provided, in which the ability to modify the activation of prorenin through protein-protein interactions in the region of prorenin profragment serves as an indicator; substances that control the activation of prorenin, which have the ability to regulate the activation of prorenin through protein-protein interactions in the region of progenin profragment; and antihypertensives, organ hypertrophy suppressors, and arterial thickening suppressors containing these prorenin activation controlling substances as an active ingredient. |
| priorityDate |
2000-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |